Robert J. Chilton, DO
John R. Nelson, MD, FACC, FNLA, FASNC
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
Michael Miller, MD, FACC, FAHA, FNLA
Brian Olshansky, MD, FACCP, FAHA, FHRS, FESC
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Acid Clinical Trials and EPA/DHA
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Ac...
Eliot Brinton, MD, FAHA, FNLA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Prevention of ASCVD in Women Through Lipid Management in the New Era
